3-Deazaadenosine hydrochloride for Reliable Assays
2026-08-29
This scenario-based guide explains how 3-Deazaadenosine hydrochloride (SKU B8470) can be used as a selective S-adenosylhomocysteine hydrolase inhibitor in methylation, proliferation, inflammation, and cytotoxicity workflows. It focuses on solvent compatibility, controls, dose interpretation, and supplier-quality checks rather than treating biochemical potency as a cellular response.
Zolmitriptan: Designing Mechanism-First Assays
2026-08-28
Zolmitriptan is a 5-HT1B receptor agonist suited to mechanism-focused migraine and cluster headache research. This article connects serotonin receptor pharmacology with evidence-driven assay design while defining the limits of extrapolating lysosomal biology findings.
Bay 11-7085: A Mechanistic NF-κB Assay Guide
2026-08-28
Bay 11-7085 is an NF-κB activation inhibitor that helps separate pathway convergence from upstream disease mechanisms. This guide translates evidence from endoplasmic reticulum stress and subarachnoid hemorrhage research into practical assay design, controls, and interpretation.
IGF2BP1–TUBB4B Signaling in Hepatic Stellate Cells
2026-08-27
The reference study identifies an m6A-dependent IGF2BP1–TUBB4B–FAK axis that promotes hepatic stellate cell activation, proliferation, and migration. Its combination of transcriptomic re-analysis, genetic perturbation, and pharmacological validation provides a framework for testing RNA-stability mechanisms in liver fibrosis while clarifying which findings remain to be validated in vivo.
IGF2BP1–TUBB4B Signaling in Hepatic Fibrosis
2026-08-27
The reference study identifies an IGF2BP1–TUBB4B–FAK pathway that connects m6A-dependent mRNA stabilization with hepatic stellate cell activation. Its integrated transcriptomic and molecular experiments suggest that TUBB4B is a functional mediator of stellate-cell proliferation, migration, and fibrogenic behavior, while also defining important considerations for methylation-pathway perturbation studies.
Hyperthermia–Cisplatin Therapy Activates Caspase-8
2026-08-26
The reference study identifies a mechanistic link between hyperthermia, cisplatin treatment, and caspase-8 accumulation, showing that this interaction can promote both apoptosis and pyroptosis in cancer cells. Its use of ubiquitination analysis, genetic perturbation, and cell-death phenotyping provides a useful framework for interpreting caspase signaling and designing follow-up apoptosis research.
Cy5.5 NHS Ester for Nanoplatform Imaging
2026-08-26
Cy5.5 NHS ester enables covalent near-infrared labeling of amine-bearing proteins, peptides, and modified oligonucleotides for tracking ultrasound-responsive nanoplatforms. This guide connects reproducible NHS-ester chemistry with biodistribution, optical imaging of tumors, and in vivo fluorescence imaging while clearly separating imaging evidence from therapeutic conclusions.
2'3'-cGAMP for STING Pathway Assays
2026-08-25
2'3'-cGAMP (sodium salt) gives researchers a defined STING-level trigger for separating cGAS activity from downstream TBK1–IRF3 signaling. This guide translates the latest hepatic ischemia–reperfusion findings into practical assay designs, controls, dosing strategies, and troubleshooting workflows for innate immunity and immunotherapy research.
ML365 and Postoperative Cognitive Impairment in Aged Mice
2026-08-25
A 2024 Brain Research study found that ML365 pretreatment improved postoperative cognitive performance in aged mice after exploratory laparotomy, while reducing hippocampal NLRP3 inflammasome-associated markers and systemic oxidative stress. The work provides a pharmacological link between K2P channel modulation and postoperative neuroinflammation, but direct TASK1 target engagement remains to be established.
Tubastatin A Alleviates Post-Resuscitation Heart Damage
2026-08-24
In a randomized porcine model of cardiac arrest and cardiopulmonary resuscitation, Tubastatin A was associated with better early myocardial function and lower cardiac injury markers. The study links this protection to reduced GSDME-associated pyroptosis and MLKL-associated necroptosis, while recognizing that pathway causality requires further validation.
Safe DNA Gel Stain for Reliable Gel Workflows
2026-08-23
Safe DNA Gel Stain combines sensitive green fluorescence with blue-light compatibility for DNA, RNA, cloning, and plant-pathology workflows. Its dual staining formats help laboratories balance rapid screening, DNA damage reduction during gel imaging, and downstream sample recovery.
Angiotensin (1-7): Workflows and Troubleshooting
2026-08-22
Build more informative renin–angiotensin system experiments by using Angiotensin (1-7) as both a Mas-receptor pathway probe and a defined analytical reference. This guide connects cell signaling, protease assays, and translational models while emphasizing peptide handling, matrix controls, and interpretation limits.
GDC-0941 PI3K Inhibitor: Applied Workflows
2026-08-21
Build reproducible PI3K/Akt pathway inhibition experiments with GDC-0941, from early pAKT pharmacodynamics to proliferation, apoptosis, resistance, and translational tumor studies. The workflow also shows how to connect PI3K perturbation with the DRD4-driven liver cancer stem cell phenotype described in recent research.
3-Deazaadenosine hydrochloride in m6A Assays
2026-08-20
3-Deazaadenosine hydrochloride provides an upstream way to test how SAHH-dependent methylation flux influences m6A-regulated cell states. This article distinguishes global methylation perturbation from IGF2BP1-specific mechanisms and translates recent hepatic stellate cell findings into better assay decisions.
Calcitriol for Bone and Immune Assays
2026-08-20
Calcitriol, or 1,25-dihydroxy vitamin D3, enables controlled studies of vitamin D receptor signaling, cytokine responses, and bone-cell remodeling. This workflow connects VDR perturbation with the new NFIA bone-homeostasis model while emphasizing stock handling, pathway-resolved controls, and troubleshooting.
461 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page